Complement receptor 1 is a risk factor for Alzheimer's disease in China, while PICALM was not See Posts
Clusterin was also unrelated in a Russian study (see posts). Good news for complement pathways, which are involved in pathogen defense and in beta-amyloid clearance. RSS feed
No comments:
Post a Comment